Advanced Therapies: Innovations in CMC Conference

Solutions for CMC challenges in the development and commercialization of cell therapy, gene therapy, and gene editing products.

Back to Agenda

Opening Remarks and Keynote Address

Senior Research Analyst

POLITICO's AgencyIQ, United States

Opening Remarks and Keynote Address

Peter W. Marks, MD, PhD

FDA, United States

Director, Center for Biologics Evaluation and Research

Have an account?